The Association of Plasma-Free Branched-Chain Amino Acids with Disease Related Parameters in Ulcerative Colitis
Abstract
:1. Introduction
2. Materials and Methods
2.1. Ethical Considerations
2.2. Participants
2.3. Assessment of Patients
2.3.1. Medical History
2.3.2. Dietary Assessment
2.3.3. Quality of Life Assessment
2.3.4. Blood Sample Collection
2.3.5. Anthropometric Assessment
2.4. Laboratory Analyses
2.4.1. Biochemical Analyses
2.4.2. Stool Inflammatory Biomarkers
2.4.3. Amino Acids Profile
2.5. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Ng, S.C.; Shi, H.Y.; Hamidi, N.; Underwood, F.E.; Tang, W.; Benchimol, E.I.; Panaccione, R.; Ghosh, S.; Wu, J.C.Y.; Chan, F.K.L.; et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 2018, 390, 2769–2778. [Google Scholar] [CrossRef]
- Levine, A.; Sigall Boneh, R.; Wine, E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut 2018, 67, 1726–1738. [Google Scholar] [CrossRef]
- Sigall-Boneh, R.; Levine, A.; Lomer, M.; Wierdsma, N.; Allan, P.; Fiorino, G.; Gatti, S.; Jonkers, D.; Kierkus, J.; Katsanos, K.H.; et al. Research gaps in diet and nutrition in Inflammatory Bowel Disease. A topical review by D-ECCO working group [Dietitians of ECCO]. J. Crohns. Colitis. 2017, 11, 1407–1419. [Google Scholar] [CrossRef] [PubMed]
- Schreiner, P.; Martinho-Grueber, M.; Studerus, D.; Vavricka, S.R.; Tilg, H.; Biedermann, L. Nutrition in Inflammatory Bowel Disease. Digestion 2020, 101, 120–135. [Google Scholar] [CrossRef] [PubMed]
- Bao, X.; Feng, Z.; Yao, J.; Li, T.; Yin, Y. Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease. Mediat. Inflamm. 2017, 2017, 6869259. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Wang, X.; Hu, C.A. Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease. Nutrients 2017, 9, 920. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Calder, P.C. Branched-Chain Amino Acids and immunity. J. Nutr. 2006, 136, 288S–293S. [Google Scholar] [CrossRef]
- Lewis, J.D.; Chuai, S.; Nessel, L.; Lichtenstein, G.R.; Aberra, F.N.; Ellenberg, J.H. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm. Bowel Dis. 2008, 14, 1660–1666. [Google Scholar] [CrossRef] [Green Version]
- Panagiotakos, D.B.; Pitsavos, C.; Stefanadis, C. Dietary patterns: A Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr. Metab. Cardiovasc. Dis. 2006, 16, 559–568. [Google Scholar] [CrossRef]
- Hlavaty, T.; Persoons, P.; Vermeire, S.; Ferrante, M.; Pierik, M.; Van Assche, G.; Rutgeerts, P. Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn’s disease. Inflamm. Bowel Dis. 2006, 12, 199–204. [Google Scholar] [CrossRef]
- Krzystek-Korpacka, M.; Kempiński, R.; Bromke, M.; Neubauer, K. Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 2020, 10, 367. [Google Scholar] [CrossRef] [PubMed]
- Merz, B.; Frommherz, L.; Ristm, M.J.; Kulling, S.E.; Achim Bub, A.; Watzl, B. Dietary pattern and plasma BCAA-variations in healthy men and women—Results from the KarMeN study. Nutrients 2018, 10, 623. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Haberman, Y.; Karns, R.; Dexheimer, P.J.; Schirmer, M.; Somekh, J.; Jurickova, I.; Braun, T.; Novak, E.; Bauman, L.; Collins, M.H.; et al. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response. Nat. Commun. 2019, 10, 38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yao, D.; Dong, M.; Dai, C.; Wu, S. Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer. Inflamm. Bowel Dis. 2019, 25, 1595–1602. [Google Scholar] [CrossRef]
- Kushkevych, I.; Castro Sangrador, J.; Dordević, D.; Rozehnalová, M.; Černý, M.; Fafula, R.; Vítězová, M.; Rittmann, S.K.-M.R. Evaluation of physiological parameters of intestinal sulfate-reducing bacteria isolated from patients suffering from IBD and healthy people. J. Clin. Med. 2020, 9, 1920. [Google Scholar] [CrossRef]
- Dordević, D.; Jančíková, S.; Vítězová, M.; Kushkevych, I. Hydrogen sulfide toxicity in the gut environment: Meta-analysis of sulfate-reducing and lactic acid bacteria in inflammatory processes. J. Adv. Res. 2020. [Google Scholar] [CrossRef]
- Gibson, G.R.; Cummings, J.H.; Macfarlane, G.T. Growth and activities of sulphate-reducing bacteria in gut contents of health subjects and patients with ulcerative colitis. FEMS Microbiol. Ecol. 1991, 86, 103–112. [Google Scholar] [CrossRef]
- Kushkevych, I.; Dordević, D.; Vítězová, M. Toxicity of hydrogen sulfide toward sulfate-reducing bacteria Desulfovibrio piger Vib-7. Arch. Microbiol. 2019, 201, 389–397. [Google Scholar] [CrossRef]
- Libert, D.M.; Nowacki, A.S.; Natowicz, M.R. Metabolomic analysis of obesity, metabolic syndrome, and type 2 diabetes: Amino acid and acylcarnitine levels change along a spectrum of metabolic wellness. Peer J. 2018, 6, e5410. [Google Scholar] [CrossRef] [Green Version]
- Benítez, J.M.; García-Sánchez, V. Fecal calprotectin: Management in inflammatory bowel disease. World J. Gastrointest. Pathophysiol. 2015, 6, 203–209. [Google Scholar] [CrossRef]
- Diamanti, A.; Knafelz, D.; Panetta, F.; Bracci, F.; Gambarara, M.; Papadatou, B.; Daniele, A.; Goffredo, G.M.; Pezzi, S.; Torre, G. Plasma citrulline as surrogate marker of intestinal inflammation in pediatric and adolescent with Crohn’s disease: Preliminary report. Int. J. Colorectal Dis. 2011, 26, 1445–1451. [Google Scholar] [CrossRef] [PubMed]
- Siomkajło, M.; Rybka, J.; Mierzchała-Pasierb, M.; Gamian, A.; Stankiewicz-Olczyk, J.; Bolanowski, M.; Daroszewski, J. Specific plasma amino acid disturbances associated with metabolic syndrome. Endocrine 2017, 58, 553–562. [Google Scholar] [CrossRef] [PubMed]
- Tobias, D.K.; Lawler, P.R.; Harada, P.H.; Demler, O.V.; Ridker, P.M.; Manson, J.E.; Cheng, S.; Mora, S. Circulating Branched-Chain Amino Acids and incident cardiovascular disease in a prospective cohort of US women. Circ. Genom. Precis Med. 2018, 11, e002157. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Andersson-Hall, U.; Gustavsson, C.; Pedersen, A.; Malmodin, D.; Joelsson, L.; Holmäng, A. Higher concentrations of BCAAs and 3-HIB are associated with Insulin Resistance in the transition from Gestational Diabetes to Type 2 Diabetes. J. Diabetes Res. 2018, 4207067. [Google Scholar] [CrossRef]
- Kumar, M.A.; Bitla, A.R.; Raju, K.V.; Manohar, S.M.; Kumar, V.S.; Narasimha, S.R.P.V.L. Branched chain amino acid profile in early chronic kidney disease. Saudi J. Kidney Dis. Transpl. 2012, 23, 1202–1207. [Google Scholar]
- van Waardenburg, D.A.; de Betue, C.T.; Luiking, Y.C.; Engel, M.; Deutz, N.E. Plasma arginine and citrulline concentrations in critically ill children: Strong relation with inflammation. Am. J. Clin. Nutr. 2007, 86, 1438–1444. [Google Scholar] [CrossRef]
- Chaleckis, R.; Murakami, I.; Takada, J.; Kondoh, H.; Yanagida, M. Individual variability in human blood metabolites identifies age-related differences. Proc. Natl. Acad. Sci. USA 2016, 113, 4252–4259. [Google Scholar] [CrossRef] [Green Version]
- Flores-Guerrero, J.L.; Osté, M.C.J.; Kieneker, L.M.; Gruppen, E.G.; Wolak-Dinsmore, J.; Otvos, J.D. Plasma Branched-Chain Amino Acids and risk of incident Type 2 Diabetes: Results from the PREVEND prospective Cohort Study. J. Clin. Med. 2018, 7, 513. [Google Scholar] [CrossRef] [Green Version]
- Pallis, A.G.; Vlachonikolis, I.G.; Mouzas, I.A. Quality of life of Greek patients with inflammatory bowel disease Validation of the Greek translation of the inflammatory bowel disease questionnaire. Digestion 2001, 63, 240–246. [Google Scholar] [CrossRef]
UC (n = 43) | HC (n = 34) | |
---|---|---|
BMI (kg/m2) | 24.5 ± 5.2 | 24.4 ± 4.1 |
≤29.9 | 38 | 30 |
≥30.0 | 5 | 4 |
Marital status | ||
Single | 17 | 29 |
Married | 23 | 5 |
Divorced | 3 | |
Disease activity | ||
PMS | 2.4 ± 2.1 | - |
IBDQ | 160.9 ± 35.4 | |
Disease duration (yrs) | 8.9 ± 6.9 | - |
Treatment | ||
Mesalazine | 35 | - |
Azathioprine | 10 | - |
Corticosteroids | 10 | - |
No treatment | 4 | - |
Albumin (g/dL) | 4.0 ± 1.1 | 5.0 ± 0.4 |
CRP (mg/dL) | 3.9 ± 5.4 | - |
Calprotectin (μg/g) | 1921.4 ± 4284.4 | - |
Lactoferrin (μg/g) | 154.6 ± 216.5 | - |
Lysozyme (μg/g) | 19.8 ± 27.3 | - |
Defensin (ng/g) | 32.6 ± 66.4 | - |
UC (n = 43) Mean ± SD | HC (n = 34) Mean ± SD | p | |
---|---|---|---|
Valine (nmol/L) | 333.7 ± 85.1 | 348.6 ± 86.4 | 0.450 |
Isoleucine (nmol/L) | 60.5 ± 22.5 | 62.1 ± 19.9 | 0.237 |
Leucine (nmol/L) | 121.2 ± 34.2 | 130.2 ± 30.5 | 0.752 |
Total BCAAs (nmol/L) | 515.4 ± 136.0 | 540.9 ± 131.1 | 0.467 |
Valine | Leucine | Isoleucine | Total BCAAs | |||||
---|---|---|---|---|---|---|---|---|
Correlation coefficient | p | Correlation coefficient | p | Correlation coefficient | p | Correlation coefficient | p | |
Age (years) | −0.169 | 0.063 | −0.190 | 0.036 | −0.184 | 0.043 | −0.233 | 0.168 |
ΒΜΙ (kg/m2) | 0.201 | 0.027 | 0.185 | 0.043 | 0.124 | 0.178 | 0.046 | 0.779 |
IBDQ | 0.052 | 0.574 | 0.02 | 0.833 | −0.039 | 0.677 | −0.044 | 0.786 |
PMS | 0.106 | 0.508 | 0.165 | 0.304 | 0.226 | 0.155 | 0.127 | 0.441 |
Calprotectin (μg/g) | −0.388 | 0.016 | −0.180 | 0.28 | −0.165 | 0.33 | −0.307 | 0.064 |
Lactoferrin (μg/g) | −0.145 | 0.422 | 0.02 | 0.91 | 0.093 | 0.611 | −0.073 | 0.69 |
Lysozyme (μg/g) | −0.286 | 0.087 | −0.210 | 0.213 | −0.190 | 0.266 | −0.252 | 0.139 |
Defensin (ng/g) | −0.170 | 0.438 | −0.014 | 0.948 | −0.090 | 0.689 | −0.142 | 0.527 |
Ulcerative Colitis | ||||||||
---|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | Model 4 | |||||
Valine * | ||||||||
B | p | B | p | B | p | B | p | |
Calprotectin (μg/g) | −1967*10−5 | 0.094 | −1759*10−5 | 0.115 | −2419*10−5 | 0.026 | −2796*10−5 | 0.007 |
Leucine * | ||||||||
B | p | B | p | B | p | B | p | |
Age (years) | −0.003 | 0.072 | −0.003 | 0.044 | −0.004 | 0.015 | −0.003 | 0.057 |
Isoleucine * | ||||||||
B | p | B | p | B | p | B | p | |
Age (years) | −0.005 | 0.023 | −0.005 | 0.020 | −0.006 | 0.006 | −0.004 | 0.031 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Papada, E.; Amerikanou, C.; Gioxari, A.; Kalogeropoulos, N.; Kaliora, A.C. The Association of Plasma-Free Branched-Chain Amino Acids with Disease Related Parameters in Ulcerative Colitis. Diagnostics 2020, 10, 798. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10100798
Papada E, Amerikanou C, Gioxari A, Kalogeropoulos N, Kaliora AC. The Association of Plasma-Free Branched-Chain Amino Acids with Disease Related Parameters in Ulcerative Colitis. Diagnostics. 2020; 10(10):798. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10100798
Chicago/Turabian StylePapada, Efstathia, Charalampia Amerikanou, Aristea Gioxari, Nick Kalogeropoulos, and Andriana C. Kaliora. 2020. "The Association of Plasma-Free Branched-Chain Amino Acids with Disease Related Parameters in Ulcerative Colitis" Diagnostics 10, no. 10: 798. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10100798